Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid immunization syndrome and thrombosis]

J C de Sousa1, F Carriço

  • 1Instituto de Trombose e Hemostase, Hospital de Santa Maria, Lisboa.

Acta Medica Portuguesa
|November 1, 1994
PubMed
Summary

Antiphospholipid Syndrome involves antibodies targeting phospholipid-protein complexes. Understanding these protein cofactors is key to diagnosing and managing this complex autoimmune disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue navigator, an important position in the Pathology laboratory in the Precision Medicine era.

ESMO open·2023
Same author

Respiratory medicine curriculum in Portuguese family medicine training: A Delphi study.

Pulmonology·2020
Same author

Pulmonary vein stenosis mimicking interstitial lung disease.

Pulmonology·2020
Same author

mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology.

Rhinology·2018
Same author

Direct evidences of enhanced Ga interdiffusion in InAs vertically aligned free-standing nanowires.

Journal of nanoscience and nanotechnology·2009
Same author

[Antithrombotic therapy in the elderly patient].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1997

Area of Science:

  • Immunology
  • Autoimmunity
  • Thrombosis

Context:

  • Antiphospholipid Syndrome (APS) is defined by specific autoantibodies and clinical events.
  • Recent research reveals autoantigens are phospholipid-protein complexes, necessitating protein cofactors.
  • This highlights the complexity beyond simple phospholipid recognition.

Purpose:

  • To revise the nature and specificity of antiphospholipid antibodies (APLs).
  • To detail the role of protein cofactors in APL formation and action.
  • To discuss diagnostic challenges and clinical variability in APS.

Summary:

  • APLs interact with specific proteins like Beta 2-Glycoprotein 1, Prothrombin, and Anexin V.
  • Immunoglobulin isotypes (IgG, IgA, IgM) are heterogeneous and can coexist.
  • Laboratory diagnosis utilizes micro ELISA systems, but clinical and lab findings show variability.

Impact:

  • Clarifies the role of protein cofactors in antiphospholipid antibody activity.
  • Improves understanding of the heterogeneous clinical and laboratory manifestations of APS.
  • Highlights the importance of accurate diagnostic approaches for antiphospholipid Syndrome.

Related Experiment Videos